Subscribe
Sergey Kolesnikov / Shutterstock.com
18 July 2024NewsAmericasLiz Hockley

ITC concludes row over biotech lab equipment between US and German rivals

Commission upholds judge’s finding that Gator Bio did not infringe lab equipment patent | Sartorius sought to assert remaining patent-in-suit covering bio-layer interferometers.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
FTC supports USPTO terminal disclaimer plan amid opposition
11 July 2024   Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation.
Biotechnology
Oura tells Texas court not to stay smart ring lawsuit pending ITC investigation
13 June 2024   Finnish health tech firm says Ultrahuman’s motion to stay would significantly prejudice case | Oura claims Indian company trying to circumvent ITC exclusion order.


Editor's picks

Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025

Editor's picks

Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025

More features

The Quintara decision: Defining trade secrets in federal cases
To disclose or not: Pharma patents face new AI reality
Trade secrets go global: How brand owners face a high-stakes battlefront
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
Former pharma GC brings in-house perspective to McGuireWoods
Sandoz eyes US biosimilar launch as Regeneron settles
Killing the golden goose of US drug innovation (Part I): Follow the money
Buchalter brings in new partner to head up medtech